CN101554190A - Edible oil containing two types of essential fatty acid - Google Patents
Edible oil containing two types of essential fatty acid Download PDFInfo
- Publication number
- CN101554190A CN101554190A CNA2008101036522A CN200810103652A CN101554190A CN 101554190 A CN101554190 A CN 101554190A CN A2008101036522 A CNA2008101036522 A CN A2008101036522A CN 200810103652 A CN200810103652 A CN 200810103652A CN 101554190 A CN101554190 A CN 101554190A
- Authority
- CN
- China
- Prior art keywords
- acid
- edible oil
- essential fatty
- oil
- linoleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
一种含有两种必需脂肪酸的食用油，为a－亚麻酸或其代谢产物按重量1∶1－10的比例与亚油酸或其代谢产物组成的混合物。本发明强调同时按比例摄入ω－6和ω－3多碳不饱和脂肪酸。本发明还涉及必需脂肪酸的配伍及其相关全民ω－3食用油、药品、功能食品、营养食品和强化食品，以保证两种必需脂肪酸，即亚油酸和a－亚麻酸在体内代谢的生物效益群最大优化，提供机体营养和用于心脑血管疾病的救治和预防。An edible oil containing two essential fatty acids, which is a mixture of a-linolenic acid or its metabolites and linoleic acid or its metabolites in a weight ratio of 1:1-10. The present invention emphasizes the simultaneous intake of omega-6 and omega-3 polycarbonate unsaturated fatty acids in proportion. The present invention also relates to the compatibility of essential fatty acids and related universal omega-3 edible oils, medicines, functional foods, nutritious foods and fortified foods, so as to ensure the metabolism of two essential fatty acids, namely linoleic acid and a-linolenic acid. The maximum benefit group is optimized to provide body nutrition and be used for the treatment and prevention of cardiovascular and cerebrovascular diseases.
Description
Technical field
The present invention relates to a kind of edible oil, relate to the edible oil of-6 two kinds of essential fatty acids of a kind of ω of containing-3 and ω particularly.
Background technology
The blending edible oil notion is rooted in the hearts of the people, and it is correct that guiding is used ready-mixed oil, but how to be in harmonious proportion, and then is the problem that people extremely pay close attention to.In fact consume oil is exactly the absorption of human body to fat, closely related with fatty acid metabolism.
Lipid in the human body, separated into two parts, that is: fat and lipoid.Fat claims triglycerides (edible oil) again, is by a part glycerine and three molecules of fatty acids be combined intos, and the aliphatic acid kind of forming natural fat is a lot, and is also different to the effect of human body.Fat can be divided into energy fat and structural fatty generally.Energy fat also claims saturated fat, mainly be made up of saturated fatty acid, be stored between people's subcutaneous connective tissue, omentum majus, mesenterium, flesh around the connective tissue and some internal organs, these fat account for 98% of the total fat of whole body, owing to can be discerned, claim " visible fat " again.The caloric value of energy fat is quite big, and with regard to same weight, its caloric value is sugar, starch, protein 2 times.Its major physiological function is an energize, can be employed when body needs, and plays the protection body, keeps the human body normal body temperature, and buffer mechanism impacts, and is fixing and protect each internal organs and organize the joint, promotes the effects such as absorption of liposoluble vitamin.Structural fatty claims " invisible fat " again, mainly is made up of many carbon unrighted acid, to constitute the form that the partes corporis humani divides the eucaryotic cell structure composition, extensively is present in the cell of brain, liver, lung, the heart, spleen, testis and musculature.Up to the present, people still can't see it, thereby claim " invisible fat " again.Structural fatty major physiological function is to constitute body, provides many carbon unrighted acid, the neuroprotective tissue.For example, to constitute the fatty material of brain important materials, be structural fatty but not energy fat.Wherein 40%～50% is many carbon unrighted acid (as DHA).Many carbon unrighted acid is the needs that make up the good brain of structure quality, is the needs that the structure quality of brain is taken a turn for the better.Many carbon unrighted acid mainly refers to linoleic acid (octadecadienoic acid), leukotrienes (octatecatrienoic acid), arachidonic acid (eicosatetraenoic acid), 20 carbon, five diluted acids and 22 carbon, six diluted acids.Wherein leukotrienes is because the position of double bond difference is divided into a-leukotrienes and gamma-Linolenic acid.In numerous unsaturated acids, linoleic acid and a-leukotrienes must be by food supplies because of not synthesized by candy, protein and other nutrients in vivo, and " essential fatty acid " is otherwise known as.The basic source of essential fatty acid is plant, animal tallow or synthetic.
Daily edible vegetable oil, no matter any, all containing visible aliphatic acid (energy aliphatic acid) is saturated fatty acid, performance provides the effect of human body energy.What people paid close attention to most is that structural fatty acid is unrighted acid, and just two kinds of essential fatty acids (linoleic acid and a-leukotrienes) are to determine human beings'health and life-span on molecular level, and are significant.
Essential fatty acid has its characteristics, one, and metabolic enzyme is identical, but the metabolite difference, collaborative performance biological effect between the metabolite.They are two years old, double key number order difference on the chemical constitution, position of double bond is also different, in order to distinguish and to discern, people are called ω-3 series with terminal double bond on third from the bottom carbon, be called ω-6 series on the 6th carbon reciprocal, linoleic acid and metabolite gamma-Linolenic acid thereof and arachidonic acid belong to ω-6 series, and a-leukotrienes and metabolite 20 carbon, five diluted acids thereof and 22 carbon, six diluted acids belong to ω-3 series.
Various aliphatic acid all are beneficial to human body, but the direction that the absorption ratio of essential fatty acid and intake will guide human fat to take in.Linoleic acid and alpha-linolenic acid have only and enter body at the same time by a certain percentage, and metabolite could the biological benefit group's effect of correct performance, otherwise will mutual restriction, and body is caused harmful effect.
At present, the edible vegetable oil of producing in China is not that the main linoleic acid that contains ω-3 series is exactly the main alpha-linolenic acid that contains ω-3 series, is necessary so be in harmonious proportion.Must have science but be in harmonious proportion, if two kinds of essential fatty acid unifications are grouped into the polyunsaturated fatty acid category, disproportional relation does not then meet the synchronous metabolism requirement of body.In fact, take much count of the absorption problem of ω-3 type essential fatty acid both at home and abroad, Japan is law-making stipulation for a long time, must add many carbon of ω-3 type unrighted acid in multiclass food, otherwise will not sell; The patent of Germany etc. countries with alpha-linolenic acid as medicine and food additives; The World Health Organization and FAO (Food and Agriculture Organization of the United Nation) just seriously issued a statement to the world in 1993, and in view of the importance of many carbon of ω-3 type unrighted acid and the situation of human general insufficiency of intake, special many carbon of ω-3 type unrighted acid that replenishes is wanted in suggestion; China scientific research personnel determines the amount of equal daily ingestion alpha-linolenic acid in the population of China half (WHO advises that everyone ate at least 2 gram/days) no more than world health organisation recommendations amount 1 gram through a large amount of nutrition investigation, mensuration.But all do not relate to the proportion compatibility of two kinds of essential fatty acids in certain specific edible product, do not emphasize that the two enters the importance of body simultaneously yet.
Linoleic acid and alpha-linolenic acid are respectively the parents of the interior ω-6 of body and ω-unrighted acid of carbon more than 3 (arachidonic acid AA, 20 carbon, five diluted acid EPA, 22 carbon, six diluted acid DHA), both and carbochain thereof prolong product and can not transform mutually, the effect trans-substitution mutually of ω-3 and ω-6 aliphatic acid has only compatibility could really embody the value of essential fatty acid.
Summary of the invention
The object of the present invention is to provide a kind of edible oil that contains two kinds of essential fatty acids, perhaps be called and contain ω-6 and ω-3 edible oil, to satisfy the demand of human body to essential fatty acid.
For achieving the above object, the edible oil that contains two kinds of essential fatty acids provided by the invention, for a-leukotrienes or its metabolite in 1: the mixture that the ratio of 1-10 and linoleic acid or its metabolite are formed.
Aforementioned proportion of the present invention has different proportion requirement according to actual needs, as popular ω-3 edible oil, a-leukotrienes: linoleic acid=1: 5-10, calculate according to taking in 25 gram edible oils for each person every day, should satisfy human body and take in above linoleic acid of 10 grams and the above a-leukotrienes standard of 2 grams every day.
Described edible oil, wherein, the linolenic metabolite of a-is eicosapentaenoic acid and DHA.
Described edible oil, wherein, linoleic metabolite is gamma-Linolenic acid and arachidonic acid.
Described edible oil, wherein, one or more in interpolation vitamin E, fat-soluble tea polyphenol, butylated hydroxy anisole (BHA), 2,6 BHTs (BHT) are as protective agent.
Described edible oil, wherein, one or more in interpolation vitamin C, organic selenium, organic germanium, the lecithin are as protective agent.
Edible oil of the present invention can be applicable to treat and prevent the medication preparation of high fat of blood, hypertension and hyperglycaemia, can also be applied in the preparation of nutraceutical.
For ease of carrying and taking, edible oil of the present invention can be made into liquid-type, oral liquid formulation and capsule formulation.
Carbon more than two kinds of the present invention do not wrap with aliphatic acid in, linoleic acid (linoleic acid) formal name used at school 9, the 12-octadecadienoic acid is all-cis formula octadecadienoic acid.Alpha-linolenic acid (α-linolenic acid is called for short leukotrienes) formal name used at school 9,12, the 15-octatecatrienoic acid is all-cis formula octatecatrienoic acid.From:
1) plant is as safflower seed oil, flax (being also referred to as flax) seed oil, perilla oil, walnut oil, sunflower oil, peanut oil, soybean oil, rape seed oil, sesame wet goods;
2) from animal such as marine animal fish etc., terraria such as horse dog chicken and duck etc.;
3) from synthetic: as linoleate, linolenate etc.
The specific embodiment
The chemical constitution of two kinds of essential fatty acids (many carbon do not wrap and aliphatic acid) that the present invention adopts is different with the position except that the double key number order, and other difference is less, because the accurate identification of carburetting enzyme has just had the difference of the two metabolite, but closely related property is arranged.
As medicine or functional food ingredients, ω-3 and ω-6 aliphatic acid all have angiocardiopathy preventing, treatment hyperlipemia, slight senile dementia, reduce the danger of cholesterolemia etc., but, if the two ratio not to or single use excessively, all can cause the safety issue of many carbon unrighted acid.
Many carbon unrighted acid (essential fatty acid) goods since its active character to make it be exposed in the air very fast generation autoxidation rotten, even produce noxious material, thereby lose its commerce and nutritive value.Although the also unspecial omega-fatty acid safety issue that proposes has some about taking in the report that heavy dose of omega-fatty acid causes the rodent changes of liver function.Raise in external sensitiveness according to the low-density lipoprotein that is rich in omega-fatty acid (LDL) to oxidation; can increase antioxidant as safeguard measure; when utilizing many carbon unrighted acid to prepare functional food; vitamin E, fat-soluble tea polyphenol, butylated hydroxy anisole (BHA), 2; 6 BHTs (BHT), vitamin C, organic selenium, organic germanium and lecithin all are antioxidant or the anti-oxidant auxiliary agents of using always; be again good physiological activator simultaneously, have cooperative effect with essential fatty acid.
Embodiment 1:
Mediation sunflower oil ratio (%)
Sunflower oil (containing linoleic acid more than 60%) 50
Siritch (containing the a-leukotrienes more than 50%) 50
Embodiment 2:
ω-3 edible oil (mediation peanut oil) ratio (%)
Peanut oil (about linoleic acid 40%) 50
Siritch (containing the a-leukotrienes more than 50%) 20
Safflower oil (linoleic acid is more than 80%) 30
Embodiment 3:
ω-3 edible oil (mediation soybean oil) ratio (%)
Soybean oil (about linoleic acid 50%) 75
Siritch (containing the a-leukotrienes more than 50%) 20
Safflower oil (linoleic acid is more than 80%) 15
Embodiment 4:
ω-3 edible oil ratio (%)
Sunflower oil (containing linoleic acid more than 60%) 84
Siritch (containing the a-leukotrienes more than 50%) 16
Embodiment 5: be used to prepare medicine
Linoleic acid has linoleic acid pill, linoleic acid compound ball (yishouning), linoleic acid compound ethyl ester ball (lipid level and Maitong) already as clinical blood lipid-lowering medicine, and shortcoming all is the linoleic acid of single component.Quasi-drugs of the present invention all should compatibility a-leukotrienes, is exactly safflower seed oil compound formulation with a-leukotrienes compatibility such as the selenizing safflower seed oil, raises the chief of safflower seed oil, keeps away the shortage of safflower seed oil.
Embodiment 6: be applied in the nutraceutical
Essential fatty acid generally not with other nutritional labeling generation chemical reaction and biological antagonist effect, as vitamins, amino acids, trace element etc.Therefore, under the situation that formulation allows, all can add essential fatty acid.As oral liquid formulation and capsule formulation.
Embodiment 7: be applied in the condensed food
With the body specific demand, be that the food of carrier is called condensed food with food, as the food of strengthening children growth, strengthen intelligence food, strengthen bone growth food etc., when these food of preparation, as long as the formulation permission all can add essential fatty acid.Selenizing safflower seed oil soft capsule is a condensed food, adds micro-organic selenium in the compatibility essential fatty acid, has both brought into play the effect of compatibility essential fatty acid, mends selenium again.
In order to verify effect of the present invention, the present invention obtains alpha-linolenic acid from siritch, be prepared into three assembly, 5 safflower seed oils by different proportion, and carry out animal reducing blood lipid test, with deep sea fish oil (many carbon of n-3 series unrighted acid) and linoleic acid product in contrast by various dose.Wherein:
Compatibility safflower seed oil A: safflower oil (containing linoleic acid 80%): alpha-linolenic acid linoleic acid mixed acid (containing alpha-linolenic acid 62%, linoleic acid 22%)=1: 4; Amount to linoleic acid: alpha-linolenic acid=1: 5;
Compatibility safflower seed oil B: safflower oil: alpha-linolenic acid linoleic acid mixed acid=2: 3; Amount to linoleic acid: alpha-linolenic acid=1.2: 1;
Compatibility safflower seed oil C: safflower oil: alpha-linolenic acid linoleic acid mixed acid=3: 2; Amount to linoleic acid: alpha-linolenic acid=2.5: 1.
Determine animal experiment dosage according to the rat mtd test, the definition heavy dose is 150mg/100g; Middle dosage is 100mg/100g; Low dose is 50mg/100g.
The result shows that these two kinds of essential fatty acids of linoleic acid and alpha-linolenic acid not only must use by compatibility, and dose-effect relationship is clear and definite, and wherein the B prescription can reduce triglyceride levels, can reduce cholesterol levels again, is better than A and C prescription.Result of the test sees Table 1.
Table 1: the compatibility safflower seed oil is to the influence of rat fat level
In the table, * compares P＜0.05 with high fat salt solution group, and * * compares P＜0.01 with high fat salt solution group
Compare with the hyperlipidemia model group, deep sea fish oil group only triglycerides (TG) reduces, and difference has statistical significance (p＜0.05); In compatibility essential fatty acid A, B, three prescriptions of C, little, in, big three dosage groups all reduce TG, difference has statistical significance (p＜0.01), effect is better than the deep sea fish oil group.Heavy dose in the B prescription can reduce cholesterol (CHOL), low-density lipoprotein (LDLC), and difference has statistical significance (p＜0.01).
The inventor selects optimization formula to prepare soft capsule, and use among the people (select the vegetable oil raw material, do not have any ill-effect), wherein to 20 hypertriglyceridemia person's tracing observations, the result is efficient to reach 100%.By with the document comparative analysis, compatibility essential fatty acid lipid-lowering effect is better than about 15 times of safflower oil (containing linoleic acid more than 80%), and the importance of compatibility has been described.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810103652.2A CN101554190B (en) | 2008-04-09 | 2008-04-09 | Edible oil containing two types of essential fatty acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810103652.2A CN101554190B (en) | 2008-04-09 | 2008-04-09 | Edible oil containing two types of essential fatty acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101554190A true CN101554190A (en) | 2009-10-14 |
| CN101554190B CN101554190B (en) | 2015-04-15 |
Family
ID=41172589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810103652.2A Active CN101554190B (en) | 2008-04-09 | 2008-04-09 | Edible oil containing two types of essential fatty acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101554190B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101919457A (en) * | 2010-09-01 | 2010-12-22 | 吴桂荣 | Blended linseed oil and applications |
| CN102696787A (en) * | 2012-06-05 | 2012-10-03 | 通化长白山药谷集团有限公司 | Edible oil containing two essential fatty acids |
| CN103766909A (en) * | 2012-10-17 | 2014-05-07 | 曾晓飞 | Novel food rich in omega-3 compounded food supplement |
| CN104983916A (en) * | 2015-07-23 | 2015-10-21 | 深圳市荣格保健品有限公司 | Heath product capable of strengthening immunity and delaying aging, preparation method and applications thereof |
| CN106267212A (en) * | 2015-05-15 | 2017-01-04 | 何灌生 | A kind of lecithin health product |
| CN106360732A (en) * | 2016-08-31 | 2017-02-01 | 刘颖 | Linoleic and linolenic acid, preparation method thereof and linoleic and linolenic acid preparation |
| CN108117926A (en) * | 2018-02-27 | 2018-06-05 | 江苏金洲粮油食品有限公司 | A kind of fit-keeping flax seed oil extractant |
| CN108384635A (en) * | 2018-02-27 | 2018-08-10 | 江苏金洲粮油食品有限公司 | A kind of efficient linseed oil extractant |
| CN112655775A (en) * | 2020-12-03 | 2021-04-16 | 刘袭文 | Selenium-rich high linoleic acid safflower seed oil |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1943372A (en) * | 2006-11-02 | 2007-04-11 | 保靖县武陵山花椒科技开发有限公司 | Linolenic acid health edible oil and prickly ash seed dregs and its preparing method |
| CN101091504A (en) * | 2007-06-12 | 2007-12-26 | 上海地源食品有限公司 | Green tea oil, and preparation method |
| CN101098628A (en) * | 2004-11-04 | 2008-01-02 | 孟山都技术公司 | Seed oil compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007121273A2 (en) * | 2006-04-11 | 2007-10-25 | Martek Biosciences Corporation | Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same |
| CN101088349B (en) * | 2006-06-13 | 2010-09-08 | 南海油脂工业(赤湾)有限公司 | Edible blend oil containing docosahexenoic acid |
-
2008
- 2008-04-09 CN CN200810103652.2A patent/CN101554190B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101098628A (en) * | 2004-11-04 | 2008-01-02 | 孟山都技术公司 | Seed oil compositions |
| CN1943372A (en) * | 2006-11-02 | 2007-04-11 | 保靖县武陵山花椒科技开发有限公司 | Linolenic acid health edible oil and prickly ash seed dregs and its preparing method |
| CN101091504A (en) * | 2007-06-12 | 2007-12-26 | 上海地源食品有限公司 | Green tea oil, and preparation method |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101919457A (en) * | 2010-09-01 | 2010-12-22 | 吴桂荣 | Blended linseed oil and applications |
| CN102696787A (en) * | 2012-06-05 | 2012-10-03 | 通化长白山药谷集团有限公司 | Edible oil containing two essential fatty acids |
| CN103766909A (en) * | 2012-10-17 | 2014-05-07 | 曾晓飞 | Novel food rich in omega-3 compounded food supplement |
| CN106267212A (en) * | 2015-05-15 | 2017-01-04 | 何灌生 | A kind of lecithin health product |
| CN104983916A (en) * | 2015-07-23 | 2015-10-21 | 深圳市荣格保健品有限公司 | Heath product capable of strengthening immunity and delaying aging, preparation method and applications thereof |
| CN104983916B (en) * | 2015-07-23 | 2016-08-24 | 深圳市荣格保健品有限公司 | There are health product of enhancing immunity and slow down aging and preparation method and application |
| CN106360732A (en) * | 2016-08-31 | 2017-02-01 | 刘颖 | Linoleic and linolenic acid, preparation method thereof and linoleic and linolenic acid preparation |
| CN108117926A (en) * | 2018-02-27 | 2018-06-05 | 江苏金洲粮油食品有限公司 | A kind of fit-keeping flax seed oil extractant |
| CN108384635A (en) * | 2018-02-27 | 2018-08-10 | 江苏金洲粮油食品有限公司 | A kind of efficient linseed oil extractant |
| CN112655775A (en) * | 2020-12-03 | 2021-04-16 | 刘袭文 | Selenium-rich high linoleic acid safflower seed oil |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101554190B (en) | 2015-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101554190B (en) | Edible oil containing two types of essential fatty acid | |
| Saini et al. | Omega− 3 polyunsaturated fatty acids (PUFAs): Emerging plant and microbial sources, oxidative stability, bioavailability, and health benefits—A review | |
| AU758079B2 (en) | Fat blend | |
| FI76678B (en) | FOERFARANDE FOER FRAMSTAELLNING AV LIPIDIEMULSION AVSEDD FOER ORAL, ENTERAL ELLER PARANTERAL NAERING. | |
| ES2256250T3 (en) | THERAPEUTIC COMBINATIONS OF FATTY ACIDS. | |
| CN101088349B (en) | Edible blend oil containing docosahexenoic acid | |
| AU2015344440A1 (en) | Optimized nutrient fatty acid composition | |
| WO2010052847A1 (en) | Concentrated liquid diet | |
| CN106490190A (en) | A kind of edible blend oil | |
| CN105533505B (en) | Chewing-type compound fish oil soft capsules and preparation method thereof | |
| CN101209089B (en) | Method for improving n-3 polyunsaturated fatty acid in grass carp meat | |
| CN100539999C (en) | Compound preparation for weight loss, fat reduction, blood sugar reduction, blood pressure reduction, and prevention and treatment of osteoporosis | |
| JPH03504868A (en) | Structured lipids containing milk fat | |
| CN101801370B (en) | Composition comprising sesamin component and arachidonic acid component | |
| Park et al. | Gamma-linolenic acid egg production enriched with hemp seed oil and evening primrose oil in diet of laying hens | |
| CN102302155B (en) | Yunnan large-leaf tea tree seed oil soft capsules | |
| Stark et al. | Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid compositions⃞ | |
| CN102524796A (en) | Vitamin A and Vitamin D supplement for infants | |
| CN104543274A (en) | DHA-containing soft candy | |
| US20070218110A1 (en) | Novel enhanced process for imparting therapeutic and nutritive levels of flaxseed to mammals | |
| US20120184760A1 (en) | Removal of monoglycerides from fatty acid concentrates | |
| JPS61118318A (en) | Composition having improving action on serum lipid | |
| CN102177982A (en) | Selenide nutrient safflower oil and selenide 3/6 balancing safflower seed oil | |
| Paul et al. | Promising functional lipids for therapeutic applications | |
| CN107372861B (en) | Composition and application thereof in preparation of product for improving hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: TONGHUA CHANGBAISHAN YAOGU GROUP CO., LTD. Free format text: FORMER OWNER: XINJIANG MEDICAL UNIVERSITY Effective date: 20100525 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 830011 NO.393, XINYI ROAD, URUMQI CITY, XINJIANG UYGHUR AUTONOMOUS REGION TO: 134001 NO.555, XINMING ROAD, XINHUA AVENUE, TONGHUA CITY, JILIN PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20100525 Address after: Xinhua Street Jilin city Tonghua province Xinming road 134001 No. 555 Applicant after: Tonghua Changbaishan Yaogu Group Co., Ltd. Address before: 830011 the Xinjiang Uygur Autonomous Region Urumqi City Xinyi Road No. 393 Applicant before: Xinjiang Medicine University |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |